1. Introduction {#s0005}
===============

As a result of brainstem stroke or neuromuscular disease, people may become completely paralyzed while their cognition remains intact (locked-in syndrome, LIS, prevalence ∼0.73--0.8 per 100,000; [@b0045], [@b0005]). For people with LIS, quality of life is correlated with the possibility to communicate adequately ([@b0055]). Augmentative and alternative communication (AAC) technology may be a solution for many people with LIS, but existing systems depend on (some level of) muscle control. A relatively new muscle-independent technology to reestablish communication in people with LIS is that of brain-computer interfaces (BCIs). BCIs typically use electrophysiologic signals that can be modulated by mental acts, such as attempted movement, or elicited by external stimuli, to generate a control signal. Recently, we showed that an implanted BCI employing subdural electrocorticographic (ECoG) electrodes can be used for reliable communication in an individual with LIS due to Amyotrophic Lateral Sclerosis (ALS) ([@b0085]). It remained to be determined, however, whether the neuro-electrical signals used for BCI control are stable in the long run and if it is possible to distinguish between brain-states chronically. Such long-term stability is vital for the eventual clinical viability of implantable BCIs since it eliminates the need for repeated surgery to reestablish control.

Prior work on long-term ECoG-recordings indirectly suggests that these signals could provide a stable BCI control signal. Animal studies have shown that placement of ECoG-electrodes does not damage the brain, besides non-harmful indentations underneath contact points and encapsulation of the electrode-strip ([@b0010], [@b0095], [@b0015]). In humans, work has been conducted on deep brain stimulation (DBS) and epilepsy monitoring. It was demonstrated that it is feasible to use ECoG-recordings for at least 6 months for the discrimination between three types of tics in Tourette's syndrome ([@b0065]), for closed-loop adaptable DBS in patients with essential tremor ([@b0020]), and for seizure detection and reduction in epilepsy patients ([@b0070], [@b0025], [@b0035]). However, recently two publications showed that the ECoG-signal recorded for seizure detection is not stable in the first 3--5 months after implantation in epilepsy patients ([@b0075], [@b0090]). This finding bears relevance to all ECoG-implants, including BCIs.

Here, we report on the long-term stability of ECoG-signals for home-use of BCIs. We extended our implantable BCI study ([@b0085]), and studied home-use, impedance, raw signal dynamics and signal modulation features over 36 months. We conclude that ECoG-based BCIs can be a long-term solution for people with LIS, since the control signal is robust and durable and BCI performance remains high, resulting in a sustainable home-use communication BCI for 36 months.

2. Methods {#s0010}
==========

We present longitudinal data from a 58-year old woman with late-stage ALS who was implanted with an ECoG-based communication BCI ([Fig. 1](#f0005){ref-type="fig"}) in 2015 ([@b0085]). Besides focusing on the primary motor cortex electrodes used for BCI control, we also report on the electrodes implanted over the left dorsolateral prefrontal cortex (dlPFC; [Fig. 1](#f0005){ref-type="fig"}), which were frequently tested but not used for everyday BCI-control. Regular recordings were obtained during a 2-year research period (November 2015--November 2017). Infrequent system-check visits allowed for additional data acquisition in the subsequent 12 months (last visit 29th of November 2018). The latter are indicated by triangles in the figures.Fig. 1Overview of the implanted brain-computer interface system. (A) Electrode-strip locations. During a first surgery, two strips were placed on the primary motor cortex and two on the dorsolateral prefrontal cortex. For both regions, one strip was placed over the primary target area, as determined using presurgical fMRI, and one was placed on a secondary target area as a backup. One strip over each area was connected to the device (see inserts) during a second surgery. These strips were selected based on correlation of the signal with the task condition of Localizer tasks performed during two days of testing between the two surgeries (see [@b0085] for details). The bipolar electrode pair e2-e3 (indicated with black circles in top right insert) is used for BCI-control. (B and C) Overview of the BCI components and the location of the implanted parts. Adapted with permission from [@b0085].

The system logs frequency and duration of home use, allowing for assessment of technology adoption between May 2016 (when she received the system at home) and April 2019. User satisfaction with the BCI system was evaluated in May 2019, using a modified Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) and Psychosocial Impact of Assistive Devices Questionnaire (PIADS) (see [@b0085] for details). The study was approved by the local Medical Ethical Committee of the UMC Utrecht. The participant gave informed consent to participate in the study using a dedicated procedure, described earlier ([@b0085]). This trial is registered in clinicaltrials.gov (NCT02224469).

2.1. Tasks and analysis {#s0015}
-----------------------

Three tasks were regularly performed from the start of the study by the participant, while ECoG-data was recorded with the implanted device. Each of these tasks involves a different level of mental activity and engagement of the user and can therefore be used to evaluate the stability of the BCI from a different perspective. The tasks were (1) a 'Localizer-task' with alternating 15 s blocks of rest and attempted hand movement, which was used to determine and track the signal features corresponding to attempted hand movement, (2) a one-dimensional continuous cursor-control ('Target') task, with attempted hand movement and rest being used to move a cursor up and down respectively. This task was used for BCI training and to study BCI performance accuracy as well as signal features in the presence of visual feedback ([@b0085]) and (3) a 'Baseline-task' with 3 min recording of both motor and dlPFC bipolar-pairs during rest with eyes open, which was used to study fluctuations of the baseline signal features over time.

Electrophysiological data was collected from bipolar pairs of electrodes using the implanted device. During the Localizer- and Baseline-tasks, time-domain data was collected at 200 Hz ('raw signal'). High-frequency band (HFB) power was calculated on an external computer with a multi-taper time-frequency transformation based on multiplication in the frequency domain (average power over 65--95 Hz, 1 Hz bins, 0.5 s Hanning window) ([@b0040]). For the Localizer-task, correlation (R^2^) of mean per trial HFB-power with the task condition (active vs rest) was calculated. Baseline-task HFB-power was averaged over time, resulting in a single value per run. During the Target-task, bandwidth filtered data, calculated on board of the device (center-frequency 80 Hz, bandwidth 2.5 Hz, using on-device analog filters; effective frequency range at these settings is 80 ± ∼10 Hz) was collected at 5 Hz ('power data'). Note that, because of the different nature of the online and offline power conversion, HFB power may differ somewhat between these methods. Yet, because for each task, HFB power was computed always using the same approach, the longitudinal HFB power profile per task can be accurately described. Target-tasks (5-min duration) were typically preceded by a 3-min calibration period, after which one or more Target-task runs were performed. Performance (percent correct hits) was calculated for each run. Empirical chance level was 48.4%, based on permutation testing. Besides performance scores, mean HFB-power during the feedback-period of active and rest trials was calculated. Clear outlier data samples were removed.

2.2. Impedance measurements {#s0020}
---------------------------

Regular impedance measurements were obtained by applying a short (80 μs, 100 Hz) pulse to each bipolar electrode-pair of the motor strip with the device (Activa PC+S, Medtronic).

2.3. Statistical testing {#s0025}
------------------------

To evaluate whether or not the BCI was stable over time, the presence or absence of a significant linear increase or decrease in HFB-power, BCI performance accuracy and impedance over time was computed by entering the respective values over time as dependent variables in linear regression models with time as the independent variable. For each model, the R^2^ value and significance (p \< 0.05) was calculated in SPSS (version 25, IBM).

3. Results {#s0030}
==========

The user received the home-system in May 2016. She reported high satisfaction with the system after several weeks of use, with scores on the PIADS of 1.1, 2.2, 1.0 for the domains competence, adaptability, and self-esteem, respectively ([@b0085]; score range is −3 to 3, larger values indicate a more positive effect of the device). Three years later (May 2019), these scores increased significantly to 2.5, 2.5 and 2.3. On the modified QUEST 2.0 questionnaire, scores on 9 of 12 items were 'very satisfied'. Two items were scored 'satisfied' and one item ('cables') was scored 'unsatisfied'. Five items received a higher score than in 2016.

System log-files showed that, initially, home use was higher during summer (April--September) than during winter (October--March), which is related to her using the system mainly outside in the first two years. Frequency and duration of BCI-system home use per month were as follows: May--September, 2016: 12.5 h and 16 times, October 2016--March 2017: 6.5 h and 6 times, April--September 2017: 10.5 h and 7 times, October 2017--March 2018: 1 h, 1 time. Starting in spring 2018, home use increased, leading to an average per month of 37.7 h (spread over 15 sessions) in April-September 2018, 98.7 h (37 sessions) in October 2018-March 2019, and 148 h (65 sessions) in April 2019. Notably, signal processing settings for home use required no changes between September 2016 and April 2019, except for a short period with fever due to reasons unrelated to the device. This increase coincided with progressive loss of eye movement control, leading the user to increasingly replace her eye tracker with the BCI system for daily communication at home. When asked about the added value of the BCI 43 months after implantation, the user expressed (literally translated from Dutch) that she was "very happy with the UNP" (UNP = Utrecht NeuroProsthesis, the implanted BCI) as "my eyes have become too slow for my eye tracking system" and with the BCI system "I can speak preprogrammed sentences and create my own words and sentences". The value of the system is further illustrated by her statement \"without the UNP I would be without words\".

3.1. Task-Related signal modulation and BCI performance {#s0035}
-------------------------------------------------------

The Localizer-task resulted in a consistently high R^2^ between HFB-power and active versus rest conditions for all but one pair on the motor strip ([Fig. 2](#f0010){ref-type="fig"}A), indicating sustained task-related modulation of HFB-power. Linear regression for all pairs did not show a change in R^2^ values over 36 months. Changes induced in HFB power by attempted hand movement could be used reliably for BCI control: performance on the Target-task (where the participant controlled vertical cursor movement on a computer screen using HFB-power from electrode pair e2-e3) was consistently high (91%, chance 48.4%, no significant trend, [Fig. 2](#f0010){ref-type="fig"}B).Fig. 2Task-related signal modulation over 36 months. (A) Correlation (R^2^) of HFB-power (65--95 Hz) with the Localizer task condition (rest vs. attempted hand movement), for all pairs on the motor electrode strip. The correlation was calculated between the mean HFB-power (over time) per trial and the task condition (active vs. rest). In red, the pair used for BCI control and home use. (B) Mean score per week on the Target-task using HFB-power of pair e2-e3 on the motor electrode strip. The Target-task was mainly used to familiarize the user with brain control. Therefore, the number of instances was higher in the first months after implantation than in the last months of this graph. Chance level is 48.4%, overall mean score was 91% (grey line), grey shading indicates the standard deviation of the mean. For both panels, the triangles represent the data collected after the research period (from November 2017).

3.2. Raw signal dynamics {#s0040}
------------------------

To track the baseline signal features over time, 3 min baseline recordings were frequently obtained. Baseline-task HFB-power of the bipolar pair over the sensorimotor cortex used for BCI-control (e2-e3) showed a slow but significant decrease over 36 months ([Fig. 3](#f0015){ref-type="fig"}A; linear regression, slope −2 × 10^−3^, R^2^ = 0.74, p \< 0.001). In contrast, HFB-power of the best performing bipolar pair on the dlPFC-strip (selected based on highest HFB correlation with a Localizer-task) was stable (slope 0.00, R^2^ = 0.032, p = 0.21). In correspondence with the findings from the Baseline task, mean HFB-power during both the active and rest trials of the Target-task (electrode pair e2-e3 over the sensorimotor cortex; [Fig. 3](#f0015){ref-type="fig"}B), averaged per week, showed a declining trend (active: slope −0.065, R^2^ = 0.79, p \< 0.001; rest: −0.052, R^2^ = 0.747, p \< 0.001).Fig. 3Chronic evaluation of ECoG-electrode parameters and HFB-power. (A) Mean HFB-power per run (65--95 Hz) HFB-power (mean per run) during the Baseline-task in the motor strip (home use pair e2-e3) in black and dlPFC-strip (best performing pair, e9-e11) in grey. The dotted lines are the linear trend lines. Shaded area surrounding the line represents the standard deviation per run. Triangles represent data acquired after the research period. Note: motor and dlPFC-strips have independent analog amplifiers on the device, therefore the absolute HFB-power values of motor and dlPFC cannot be compared. (B) HFB-power (pair e2-e3 of the motor strip) during the active (black) and rest (grey) phase of the Target-task. Note that due to the analogue filtering on board of the device (center frequency 80 Hz, bandwidth 2.5 Hz; effective frequency range at these settings is 80 ± ∼10 Hz) the power values differ from the calculated power values in panel A. The dotted lines are the linear trend lines, the shaded area surrounding the line represents the standard deviation, and the triangles represent data acquired after the research period. Note that HFB power appears to stabilize after week 112. (C and E) Electrode pair impedances over time. Colored lines indicate values per electrode pair, averaged per month. In black the mean over all pairs of the motor strip, in red the pair used for control. Panel A shows the impedance values obtained using stimulation at 0.25 V. Panel C shows the values obtained after stimulation settings were increased to 0.7 V in April 2016 when some recordings using 0.25 V reached the maximum displayable value of 4000 Ω. Triangles represent the data collected after the research period (from November 2017). (D) Linear regression results of the impedances in panels A and C. During the first 5 months, a significant increase in impedance was found in all electrode pairs. From April 2016 onwards the impedances stabilized for all but 4 pairs (e1-e3, e1-e4, e2-e4 and e3-e4).

3.3. Impedance {#s0045}
--------------

Impedance displayed a significant (p \< 0.05, linear regression) increase for all motor bipolar pairs in the first months after implantation ([Fig. 3](#f0015){ref-type="fig"}C/D). After 5 months, slow trends were still observed but impedances generally stabilized around 3500 Ohm ([Fig. 3](#f0015){ref-type="fig"}E).

4. Discussion {#s0050}
=============

BCI-control based on ECoG signals from the motor cortex is consistently high, and supports sustainable BCI home use for 36 months. Despite a slow decline in HFB-power in active and resting states, discrimination between states remains excellent, as demonstrated by stable high R^2^ values, high performance (91%), and system adoption by the user, as evidenced by increasing home use. A decline in baseline HFB-power (54--86 Hz) has been shown for non-human primates ([@b0060]), and was attributed to regrowth of dura between electrode and leptomeningeal surface. This is unlikely to explain the decline in HFB-power in our study, since we did not observe this phenomenon in the dlPFC-strip. One explanation could be that the patient improved downregulation of HFB-power during baseline and needed less increase for reliable control. Indeed, the user reported decreased effort over time ([@b0085]). Alternatively, the HFB-power decline could reflect neurodegenerative characteristics of ALS, where the motor cortex degenerates and Betz cells, which are likely to contribute to HFB-power ([@b0050]), are depleted ([@b0030]). Impedance stabilized 5 months after implantation. The initial rise and subsequent stabilization of impedance values corresponds to earlier reports ([@b0070], [@b0080]).

5. Conclusion {#s0055}
=============

In conclusion, our data show that, despite small changes in impedance and HFB-power, accurate and stable long-term ECoG-based BCI control was feasible in a person with LIS due to ALS. These findings bear relevance for the growing field of sensing neurotechnology, including BCIs and responsive DBS, but should be confirmed in other individuals and brain areas, and in different etiologies.
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